Literature DB >> 21934090

What is the prognostic significance of pulmonary hypertension in heart failure?

Neal A Chatterjee, Gregory D Lewis.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21934090      PMCID： PMC3740214          DOI： 10.1161/CIRCHEARTFAILURE.111.963785

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN： 1941-3289            Impact factor:   8.790


× No keyword cloud information.
  40 in total

1.  Value of right ventricular ejection fraction in predicting short-term prognosis of patients with severe chronic heart failure.

Authors:  A Gavazzi; C Berzuini; C Campana; C Inserra; M Ponzetta; R Sebastiani; S Ghio; F Recusani
Journal:  J Heart Lung Transplant       Date:  1997-07       Impact factor: 10.247

2.  Additional predictive value of both left and right ventricular ejection fractions on long-term survival in idiopathic dilated cardiomyopathy.

Authors:  Y Juillière; G Barbier; L Feldmann; A Grentzinger; N Danchin; F Cherrier
Journal:  Eur Heart J       Date:  1997-02       Impact factor: 29.983

3.  Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure.

Authors:  T G Di Salvo; M Mathier; M J Semigran; G W Dec
Journal:  J Am Coll Cardiol       Date:  1995-04       Impact factor: 24.094

4.  Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide.

Authors:  John J Lepore; Anjli Maroo; Luca M Bigatello; G William Dec; Warren M Zapol; Kenneth D Bloch; Marc J Semigran
Journal:  Chest       Date:  2005-05       Impact factor: 9.410

5.  Determinants of pulmonary hypertension in left ventricular dysfunction.

Authors:  M Enriquez-Sarano; A Rossi; J B Seward; K R Bailey; A J Tajik
Journal:  J Am Coll Cardiol       Date:  1997-01       Impact factor: 24.094

Review 6.  Determinants of the pulmonary artery pressure rise in left ventricular dysfunction.

Authors:  C M Tribouilloy; M Enriquez-Sarano; A Rossi; A J Tajik; J B Seward
Journal:  Cardiologia       Date:  1997-10

Review 7.  Narrative review: the enigma of pulmonary arterial hypertension: new insights from genetic studies.

Authors:  John H Newman; John A Phillips; James E Loyd
Journal:  Ann Intern Med       Date:  2008-02-19       Impact factor: 25.391

8.  Hemodynamic effects of inhaled nitric oxide in heart failure.

Authors:  M J Semigran; B A Cockrill; R Kacmarek; B T Thompson; W M Zapol; G W Dec; M A Fifer
Journal:  J Am Coll Cardiol       Date:  1994-10       Impact factor: 24.094

9.  Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension.

Authors:  Gregory D Lewis; Ravi Shah; Khurram Shahzad; Janice M Camuso; Paul P Pappagianopoulos; Judy Hung; Ahmed Tawakol; Robert E Gerszten; David M Systrom; Kenneth D Bloch; Marc J Semigran
Journal:  Circulation       Date:  2007-09-04       Impact factor: 29.690

10.  Acute phosphodiesterase 5 inhibition mimics hemodynamic effects of B-type natriuretic peptide and potentiates B-type natriuretic peptide effects in failing but not normal canine heart.

Authors:  Paul R Forfia; Myung Lee; Richard S Tunin; Mobusher Mahmud; Hunter C Champion; David A Kass
Journal:  J Am Coll Cardiol       Date:  2007-02-26       Impact factor: 24.094
View more
  6 in total

1.  It is time to look at heart failure with preserved ejection fraction from the right side.

Authors:  Neal A Chatterjee; Johannes Steiner; Gregory D Lewis
Journal:  Circulation       Date:  2014-11-12       Impact factor: 29.690

Review 2.  Comprehensive and Safe Decongestion in Acutely Decompensated Heart Failure.

Authors:  Jason Stencel; Indranee Rajapreyar; Rohan Samson; Thierry Le Jemtel
Journal:  Curr Heart Fail Rep       Date:  2022-09-01

3.  Arterial-ventricular and interventricular interaction in isolated post-capillary and combined pulmonary hypertension in severe mitral stenosis.

Authors:  Ashwin Venkateshvaran; Srikanth Sola; Satish Chandra Govind; Pravat Kumar Dash; Sagar Vyavahare; Lars H Lund; Bé la Merkely; Anikó Ilona Nagy; Aristomenis Manouras
Journal:  Eur J Appl Physiol       Date:  2016-05-19       Impact factor: 3.078

Review 4.  WHO's in second?: A practical review of World Health Organization group 2 pulmonary hypertension.

Authors:  Sif Hansdottir; Dayna J Groskreutz; Brian K Gehlbach
Journal:  Chest       Date:  2013-08       Impact factor: 9.410

5.  Cine MRI characterizes HFpEF and HFrEF in post-capillary pulmonary hypertension.

Authors:  Kai Lin; Roberto Sarnari; Ashitha Pathrose; Daniel Z Gordon; Julie Blaisdell; Michael Markl; James C Carr
Journal:  Eur J Radiol       Date:  2021-03-26       Impact factor: 4.531

6.  Characterisation of the patients with suspected heart failure: experience from the SHEAF registry.

Authors:  Pankaj Garg; Ahmed Dakshi; Hosamadin Assadi; Andrew J Swift; Umna Naveed; Graham Fent; Nigel Lewis; Dominic Rogers; Athanasios Charalampopoulos; Abdallah Al-Mohammad
Journal:  Open Heart       Date:  2021-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.